The most updated, intensive and quality training, with the most complete theoretical knowledge in Pediatric Infectious Diseases and the opportunity to put it to the test during the subsequent practical training in a reference hospital"

The increasingly frequent availability of novel techniques in the area of Pediatric Infectious Diseases allows for faster and more effective diagnoses. At the same time, this medical sector has incorporated different technological resources such as ultrasound scans, CT scans and others to detect different pathogens. This is in addition to innovation in laboratory testing. On the other hand, in the therapeutic scenario, treatments based on immunomodulatory proteins and other therapies based on potent antibiotics and antivirals have become more widespread, and in view of this constant evolution, it is essential for professionals to update their knowledge in order to implement the most innovative procedures based on current scientific evidence.

In this context, TECH has designed an innovative program consisting of two distinct educational phases. The first of these, of a theoretical nature, will delve into the latest innovations in this health area with special attention to the combination of techniques and tools for the diagnosis of different pathologies. These subjects, as well as the most advanced therapeutic strategies of the moment, will be collected in a 100% online and interactive learning platform. The program is based on didactic methods such as Relearning and the discussion of various case studies.

Likewise, in the practical training of this Hybrid professional master’s degree, the pediatrician will have access to a highly demanding hospital center where they will be able to put into practice everything they have learned. This intensive, face-to-face stay will be extended for 3 weeks, until 120 educational hours have been completed. In these institutions, the physician will work directly with leading experts in this field of health and, at the same time, will be supervised by an assistant tutor. You will also have the opportunity to handle novel technologies and apply your new skills in the specialized care of real patients. In short, this is a unique academic experience that will bring you up to date on the main innovations in Pediatric Infectious Diseases in just one year.

You will enjoy an intensive 3-week stay in a prestigious clinical center where you will be able to catch up on the latest advances in Pediatric Infectious Diseases"

This Hybrid professional master’s degree in Pediatric Infectious Diseases contains the most complete and up-to-date scientific program on the market. The most important features include: 

• More than 100 clinical cases presented by experts in the different specialties. Its graphic, schematic and practical contents, which are designed to provide scientific and healthcare expertise in medical disciplines that are essential for professional practice
• Comprehensive systematized action plans for major pathologies
• Presentation of practical workshops on procedures diagnosis, and treatment techniques
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
• Practical clinical guides on approaching different pathologies
• With a special emphasis on evidence-based medicine and research methodologies
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection
• In addition, you will be able to carry out a clinical internship in one of the best hospitals in the world

Through this program you will be able to complete your studies by doing your internship in a hospital equipped with the technological means and approaches of the future, with the best medical technology and alongside renowned specialists in this medical field"

In this Professional Master’s Degree proposal, of a professionalizing nature and blended learning modality, the program is aimed at updating medical professionals in the field of Pediatric Infectious Diseases. The contents are based on the latest scientific evidence, and oriented in a didactic way to integrate theoretical knowledge into practice, and the theoretical-practical elements will facilitate the updating of knowledge and will allow decision making in patient management.

Thanks to its multimedia content developed with the latest educational technology, they will allow the professional a situated and contextual learning, that is to say, a simulated environment that will provide an immersive learning programmed to train in real situations. The design of this program focuses on Problem Based Learning, through which the student will have to try to solve the different professional practice situations that will arise throughout the program. This will be done with the help of an innovative interactive video system developed by renowned experts with extensive teaching experience.

This Hybrid professional master’s degree allows you to practice, first, in simulated environments that provide immersive learning, and then in the real hospital environment testing everything you have studied"

Update your knowledge through this theoretical and practical program, in a fast way and adapted to your needs"

The program of studies for this program, composed of various modules of interest, delves into the current landscape of infectious diseases. It also examines the most advanced diagnostic techniques to determine the presence of infectious diseases in children's bodies. At the same time, it provides an in-depth study of the most complete prophylactic procedures to prevent the spread of different pathologies of this type in the hospital, community and school settings. The specialist will get up to date on these contents from a learning platform, 100% online, with the help of innovative didactic methods such as Relearning.

This program is not subject to rigid schedules or pre-established evaluation chronograms so that you can personalize your learning at all times"

Module 1. Current Overview in Infectious Diseases

1.1. Update on Epidemiological and Public Health Aspects

1.1.1. Current Status of the Epidemiology of Vaccine-Preventable Diseases in the World

1.2. Current Epidemiology of Relevant Infectious Pathologies in our Environment

1.2.1. Current Epidemiology of Bacterial Meningitis
1.2.2. Current Epidemiology of Poliomyelitis and Flaccid Paralysis due to Non-Poliovirus and Live Attenuated Virus Vaccine
1.2.3. Epidemiology of Tuberculosis and its Resistance in High-Income Countries
1.2.4. Epidemiology of Sexually Transmitted Infections in Adolescents

1.3. Transmission Mechanisms in Pediatrics

1.3.1. Dynamics and Transmission Mechanisms of the Most Common Agents in Pediatrics Today (Includes Intrafamily Transmission)
1.3.2. Seasonality of Infection in Pediatrics Outbreak Management

1.3.2.1. Temporal Epidemiological Parameters in the Most Common Infections in the Community, Common Point Sources, Continuous, Propagative and Mixed exposure

1.4. Microbiota, Defensive and Immunomodulatory Function

1.4.1. Composition of the Intestinal Flora, Modification with Age
1.4.2. Defensive and Immunomodulatory Role of the Microbiota

1.5. Fever and Inflammatory Response

1.5.1. Update on the Role of Fever in Infection and Antipyretic Therapeutics
1.5.2. Inflammatory Response and Systemic Inflammatory Response Syndrome

1.6. Infections in the Immunocompromised Patient
1.7. Image Interpretation of Infectious Diseases in the Pediatric Age

1.7.1. Interpretation of Ultrasound Images Applied to Infectious Pathology
1.7.2. Interpretation of TC Applied to Infectious Pathology
1.7.3. MRI Interpretation Applied to Infectious Pathology.

Module 2. The Laboratory in the Diagnosis of Infectious Diseases

2.1. Sample Collection

2.1.1. Urine culture
2.1.2. Stool Culture
2.1.3. Graham's Test
2.1.4. Blood Cultures
2.1.5. Catheters
2.1.6. Ocular System
2.1.7. Upper Respiratory Tract
2.1.8. Lower Respiratory Tract
2.1.9. Cerebrospinal Fluid
2.1.10. Skin and Soft Tissues
2.1.11. Osteoarticular Infections
2.1.12. Bone Marrow

2.2. Current Application of Rapid Infection Diagnosis Methods in Primary and Specialized Care

2.2.1. Antigen Detection
2.2.2. Direct Sample Staining
2.2.3. Urgent Serology
2.2.4. Molecular Biology Techniques
2.2.5. Accelerating Antimicrobial Susceptibility Testing
2.2.6. Current Proteomic Techniques for the Diagnosis of Infectious Diseases
2.2.7. Shared Microbiologist-Clinician Decisions in Diagnosis and Treatment of Infectious Diseases

2.3. Antibiograms

2.3.1. Interpretation of Antibiograms Practical Guide
2.3.2. Clinical Significance of Bacterial Resistance

2.4. Interpretation of the Microbiological Report of Respiratory Specimens
2.5. Interpretation of the Microbiological Report of Specimens from the Genitourinary Tract and Gastrointestinal Tract
2.6. Interpretation of the Microbiological Blood Culture Report
2.7. Interpretation of Cerebrospinal Fluid Microbiology Report
2.8. Interpretation of the Microbiological Report in Osteoarticular Infection
2.9. Interpretation of the Microbiological Report of Skin and Soft Tissue Samples

Module 3. Infection in the Neonatal Period

3.1. Neonatal Infection

3.1.1. Current Obstetric Factors Conditioning Neonatal Infection
3.1.2. Causative Agents

3.2. Antibiotherapy in Pregnancy

3.2.1. Current Role of Antibiotherapy During Pregnancy
3.2.2. Current Prophylaxis of Group B Streptococcus Infection

3.3. Emerging Congenital Infections

3.3.1. Chagas Disease
3.3.2. Zika

3.4. Classical Neonatal Infections and Current Epidemiologic Changes

3.4.1. Herpes Virus Infections
3.4.2. Rubella
3.4.3. Cytomegalovirus
3.4.4. The Son of a Mother with Tuberculosis
3.4.5. Update on Necrotizing Enterocolitis

3.5. Vertical Infection

3.5.1. Update on Vertical Infection by Hepatitis B Virus and its Detection

3.6. Neonatal Sepsis

3.6.1. Early Sepsis
3.6.2. Late Onset Sepsis

3.7. Infections in the Neonatal Intensive Care Unit

3.7.1. Current Algorithm of Action for Fever in Children under 30 Days of Age.
3.7.2. Neonatal Fungal Infection

3.8. Laboratory Studies in Neonatology Units

3.8.1. Etiological Identification
3.8.2. Inflammatory Markers
3.8.3. Multiorgan Markers

Module 4. Eye, Skin, Soft Tissue and Skeletal System Infections.

4.1. Bacterial or Viral Conjunctivitis
4.2. Dacryocystitis
4.3. Endophthalmitis
4.4. Preseptal and Postseptal Orbital Cellulitis
4.5. Bacterial Skin Infections
4.6. Viral Skin Infections
4.7. Parasitic Skin Infections
4.8. Dermatophyte Skin Infections
4.9. Candida and Malasezzia Skin Infections
4.10. Involvement of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Pediatric Skin and Soft Tissue Infections in our Environment
4.11. Adenitis
4.12. Lymphangitis
4.13. Necrotizing Fasciitis
4.15. Bite Infections

4.15.1. Bites in Urban Environment
4.15.2. Bites in Rural Environment

4.16. Osteomyelitis and Arthritis
4.17. Myositis and Pyomyositis
4.18. Spondylodiscitis

Module 5. ENT and Respiratory Infections

5.1. Pharyngotonsillitis
5.2. Peritonsillar Regional Abscesses and Lemierre's Syndrome

5.2.1. Abscesses in Periatonsillar Region
5.2.2. Mastoiditis

5.3. Otitis and Mastoiditis
5.4. Sinusitis
5.5. Update on Diphtheria
5.6. Oral mucosa infections Odontogenic Infections
5.7. Common Cold
5.8. Influenza in Pediatrics
5.9. Pertussis Syndrome
5.10. Update on Bronchiolitis Treatment
5.11. Community-Acquired Pneumonia (CAP)

5.11.1. Etiological Agents by Age
5.11.2. Diagnosis
5.11.3. Severity Factors
5.11.4. Treatment

5.12. Pleural Empyema
5.13. Tuberculosis

5.13.1. Current Guidelines
5.13.2. Infections
5.13.3. Disease
5.13.4. Diagnosis
5.13.5. Treatment

Module 6. Gastrointestinal and Urinary Tract Infections and STDs

6.1. Acute Gastroenteritis.

6.1.1. Current Management

6.2. Traveler's Diarrhea in Children
6.3. Current Role of Parasites in Diarrheal Syndromes in our Environment.
6.4. Update on Hepatitis A and E
6.5. Hepatitis B y Hepatitis C

6.5.1. Current Treatment Options
6.5.2. Risk Factors for Disease Progression
6.5.3. Current Treatment Options

6.6. Update on Clostridium Difficile in Pediatrics
6.7. Acute Appendicitis in Children

6.7.1. Need or Not of Antibiotic Treatment

6.8. Urinary Infection

6.8.1. Current Treatment Management
6.8.2. Complementary Evaluations
6.8.3. Prophylaxis
6.8.4. Role of Vesicoureteral Reflux

6.9. Epidemiology, Clinical Manifestations, Diagnosis and Treatment of the Most Common Sexually Transmitted Infections

6.9.1. Syphilis
6.9.2. Gonorrhea
6.9.3. Papillomavirus
6.9.4. Chlamydia Trachomatis
6.9.5. Herpes Virus 1 and 2

6.10. Perirectal Abscesses

Module 7. Febrile Syndromes and Exanthems

7.1. Fever Without a Focus in Children Less than 3 Months Old

7.1.1. Algorithm of Action
7.1.2. Fever of Unknown Origin in Pediatrics

7.2. Recurrent and Periodic Fever

7.2.1. Differential Diagnosis

7.3. Leishmaniasis
7.4. Exanthematous Diseases and Differential Diagnosis
7.5. Mycoplasma Pneumoniae Non-Pulmonary Pathology

Module 8. Nosocomial Infections.

8.1. Healthcare Associated Infections (HAIs) in Pediatrics
8.2. Device-Associated Infections

8.2.1. Infections Associated with Intravascular Devices
8.2.2. Ventilator-Associated Infections

8.3. Infection of Surgical Wounds Current Management

Module 9. HIV Infection in Pediatrics and Adolescence

9.1. Vertical Transmission

9.1.1. Current Situation of Vertical Transmission in our Environment
9.1.2. Prevention and Management

9.2. Infection in Adolescents
9.3. Antiretrovirals in Pediatrics

9.3.1. Updates
9.3.2. Combinations
9.3.3. Determination of Resistance
9.3.4. Side Effects and Metabolic Alterations

9.4. Pharmacokinetics

9.4.1. Interactions
9.4.2. Level Monitoring

9.5. When and How to Start HAART
9.6. Current Management of HBV and HCV Coinfection

Module 10. Systemic, Cardiovascular and Nervous System Infections

10.1. Endocarditis
10.2. Bacterial Meningitis

10.2.1. Action in Case of Suspicion

10.3. Viral Meningitis

10.3.1. Current Agents

10.4. Cerebral Absess

10.4.1. Infections Associated with Surgical Procedures
10.4.2. Venous Thrombosis

10.5. Cat scratch Disease
10.6. Mononucleosis Syndromes
10.7. Hemorrhagic Fevers

10.7.1. Diagnosis
10.7.2. Treatment

10.8. Endocarditis
10.9. Pericarditis
10.10. Encephalitis
10.11. Sepsis, Severe Sepsis and Septic Shock in Pediatrics

Module 11. Infections associated with Social Changes or Deficits

11.1. Infections associated with Social Deficits

11.1.1. Infections Associated with Social Deficits
11.1.2. Current Child Poverty and Infections in our Environment

11.2. Tropical Diseases

11.2.1. Initial Infectiological Examination of Newly Arrived Immigrant Children and Children from International Adoptions.
11.2.2. Febrile Syndrome in the Child Coming from a Low-Income Country or from the Tropics, Regardless of the Reason for the Trip.
11.2.3. Malaria. Current Diagnostic and Therapeutic Management
11.2.4. Vector-Borne Infections Dengue. Chikungunya Zika
11.2.5. Vector-Borne Diseases Schistosomiasis Onchocerciasis
11.2.6. Parasitic Diseases Ascaris, Amoebas, Tenias, Oxyuris, Strongyloides, Trichuris Trichiura

Module 12. Infection in the Patient at Risk

12.1. Children with Immunomodulatory Treatments in Rheumatology

12.1.1. Management of Patients Undergoing Immunomodulatory Treatments

12.2. Current Empiricism of Infections in Oncology Patients.

12.2.1. Adenovirus Infections in Hemato-Oncology
12.2.2. Diagnostic and Therapeutic Approach to Febrile Neutropenia in Cancer Patients
12.2.3. Empirical and Targeted Treatment of Infections in Cancer Patients

12.3. Infections and Current Response to Children with Underlying Pathology

12.3.1. Risk infections in Patients with Hemolytic Anemias (emoglobinopathies and Membranopathies)
12.3.2. Treatment of Severe Neutropenia and Congenital and Functional Asplenia
12.3.3. Infections in Children with Cystic Fibrosis

12.4. Current Approach to Infections in the Transplanted Child

12.4.1. Cytomegalovirus and BK Virus Infections in Transplant Recipients

Module 13. Treatment in Pediatric Infectious Diseases

13.1. Pharmacokinetics and Pharmacodynamics of Antibacterial Agents in Pediatrics
13.2. Bacterial Resistance and Antibiotherapy

13.2.1. Carbapenem-Resistant Enterobacteriaceae, BLES, MRSA, Vancomycin-Resistant
13.2.2. Resistance to Antifungals

13.3. Choice of Antibiotics in the Different Families

13.3.1. Beta-Lactams
13.3.2. Macrolides
13.3.3. Aminoglycosides
13.3.4. Fluoroquinolones

13.4. Choice Among the Different Families of Antifungals

13.4.1. Azoles
13.4.2. Echinocandins
13.4.3. Polyenes

13.5. Resurrection of Old Therapeutic Agents
13.6. New Antibiotics or Families

13.6.1. Ceftobiprole, Ceftaroline, Doripenem, Dalbavancin, Talavicina, Teixobactin, Ceftolozane-Tazobactam, Ceftazidime-Avibactam, Lugdunin, Oritavancin, Iclaprim, Ramoplanin, Fidaxomicin, Fidaxomicin.

13.7. New Tuberculostatics
13.8. Antibiotherapy in Obese Pediatric Patients
13.9. New Requirements for the Rational and Judicious Choice of Suitable Treatment

13.9.1. Antibiotic Policy in Hospitals and Primary Care Optimization Program

13.10. Role of Agriculture and Animal Husbandry in Antibiotic Resistance
13.11. Use of Antivirals

13.11.1. In Immunocompetent Patients
13.11.2. Use of Antivirals in Immunocompromised Patients

13.12. Essential Antiparasitic Drugs in Pediatrics
13.13. Update on Allergy to Anti-Infectives Alternatives
13.14. Monitoring of Anti-Infectives
13.15. Update on the Duration of Antibiotic Treatments

Module 14. Preventive Measures

14.1. Control and Response to Hospital Outbreaks of Infection

14.1.1. Common Microorganisms
14.1.2. Current Multidrug-Resistant Microorganisms (Including Decontamination in the MRSA Patient)

14.2. Hospital Organization and Control of Today's Multidrug-Resistant Microorganisms
14.3. Current Indications for Isolation in Hospital Pediatrics
14.4. Current Vaccines

14.4.1. Prematurity
14.4.2. Immunodeficient Child
14.4.3. Child Undergoing Immunosuppressive Treatments
14.4.4. Splenectomized Patients
14.4.5. Transplant Recipients
14.4.6. HIV

14.5. Update on Vaccination of Children in Special Situations
14.6. Current Indications for Antibiotic Prophylaxis
14.7. Indications for Prophylaxis

14.7.1. In case of Accidental Puncture
14.7.2. Indications for Sexual Abuse Prophylaxis

14.8. Post-Exposure Performance

14.8.1. Chickenpox
14.8.2. Measles
14.8.3. Hepatitis B
14.8.4. Hepatitis A
14.8.5. Tuberculosis
14.8.6. Tetanus
14.8.7. Rabies

14.9. Current Status of Perioperative Prophylaxis of the Surgical Patient
14.10. Update on Antibiotic Prophylaxis in Transplant Children and Patients Treated for Atypical Hemolytic Uremic Syndrome

Module 15. Public Health Infectious Disease Control and Research

15.1. Emerging Infectious Diseases
15.2. Diseases in Which Contact Study is Currently Indicated
15.3. Mandatory Disease Reporting and its Practical Significance
15.4. Indications of Directly Observed Treatment
15.5. Ethics in the Research of New Antibiotics, Antivirals, Antifungals or Vaccines
15.6. How to Plan a Study in Infectious Diseases?
15.7. Evaluation and Critical Reading of Scientific Publications
15.8. Current Morbidity and Mortality of Pediatric Infectious Diseases
15.9. Seasonality of Infection in Pediatrics

A unique, key and decisive training experience to boost your professional development that will put you at the forefront of the professional world”